Orchestra BioMed Holdings, Inc.
OBIO
$4.49
-$0.08-1.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3,490.82% | 2.99% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3,490.82% | 2.99% | |||
| Cost of Revenue | 4.08% | 6.52% | |||
| Gross Profit | 3,701.23% | 2.78% | |||
| SG&A Expenses | 2.69% | 13.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.12% | 5.01% | |||
| Operating Income | 133.25% | -5.10% | |||
| Income Before Tax | 129.98% | -7.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 129.98% | -7.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 129.98% | -7.57% | |||
| EBIT | 133.25% | -5.10% | |||
| EBITDA | 133.79% | -5.12% | |||
| EPS Basic | 124.23% | 20.86% | |||
| Normalized Basic EPS | 125.26% | 20.88% | |||
| EPS Diluted | 124.23% | 20.86% | |||
| Normalized Diluted EPS | 125.26% | 20.88% | |||
| Average Basic Shares Outstanding | 18.74% | 35.93% | |||
| Average Diluted Shares Outstanding | 18.74% | 35.93% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||